Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade. [electronic resource]
Producer: 20180425Description: 23 p. digitalISSN:- 2051-1426
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- B7-H1 Antigen -- antagonists & inhibitors
- Carcinoma, Basal Cell -- drug therapy
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Hedgehog Proteins -- antagonists & inhibitors
- Humans
- Lymphocytes, Tumor-Infiltrating -- drug effects
- Male
- Middle Aged
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Tumor Microenvironment -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.